GLP-1 agonists didn't launch claiming to treat diabetes, obesity, heart disease, and neurodegeneration simultaneously — they proved one indication rigorously and then earned additional ones as evidence accumulated over years.
Snapshot · The Peter Attia Drive
GLP-1 agonists didn't launch claiming to treat diabetes, obesity, heart disease, and neurodegeneration simultaneously — they proved one indication rigorously and then earned additional ones as evidence accumulated over years.
Where this was said
At 21:18 · chapter starts 20:45
Nick raises a natural devil's advocate question: couldn't expanding claims across multiple therapeutic areas suggest a genuinely broad biological mechanism rather than be a warning sign? Peter is unequivocal. A drug can have broad effects, but only when it hits a fundamental, well-characterized pathway and earns that breadth through evidence. GLP-1 agonists are the model: they started with one indication, proved it rigorously, and then accumulated additional indications as evidence mounted over years. BPC-157 has done the exact opposite — wound healing became tendons, ligaments, muscle, gut disease, inflammation, pain, performance, recovery, and even multiple sclerosis, all without nailing down the first claim in a human trial. [1] — Peter Attia "Real drugs earn new indications through rigorous sequential trials. BPC-157 did the opposite — its claimed benefits expanded from wound hea…" 20:50 The pattern that most troubles Peter is that the missing evidence is not a matter of resources or time; human RCTs are possible but aren't happening, or are happening and the results aren't being published. Legitimate drug development narrows uncertainty over time. Bad or absent science expands claims instead — and BPC-157 has been on the second track for three decades.
Real drugs earn new indications through rigorous sequential trials. BPC-157 did the opposite — its claimed benefits expanded from wound healing to tendons, gut, inflammation, performance, and MS without ever proving a single human indication. Expanding claims without narrowing uncertainty is the signature of a marketing campaign.
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
Men's overdose death rate fell 27% in a single year, outpacing the 23% drop for women.
The steepest decline in overdose deaths was among 15–24-year-olds, whose rate fell 37%.
Fei-Fei Li observed that on a given hospital shift, nurses walk miles just to fetch medicine and supplies, illustrating a clear use case for assistive robotics in healthcare.
Before becoming the Bachelorette, Robby's wife Gabby Windey worked as an ICU nurse for years.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.